Security key
76155X100
Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD)
CUSIP: 76155X100
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 57,426,011
- Total 13F value
- $2,273,517,142
- Share change
- +3,279,530
- SEC-reported price per share
- $39.59
- Number of holders
- 118
- Value change
- +$133,648,027
- Number of buys
- 73
- Number of sells
- 33
- Shares outstanding
- 215,912,396
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
118
Top holders
10
RVMD full security history
Ownership snapshot
Full 13F holder table
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RVMD - Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F
Highest disclosed value: $344,135,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $344.14M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$344.14M
TRV GP III, LLC
$279.24M
Peter Svennilson
$277.61M
VANGUARD GROUP INC
$120.06M
Boxer Capital, LLC
$115.16M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$344,135,000
9,888,961 shares
|
— | 30 Sep 2020 |
| TRV GP III, LLC |
13F
Company
|
—
denominator unverified
|
$279,236,000
8,024,031 shares
|
— | 30 Sep 2020 |
| Peter Svennilson |
13F
Individual
|
—
denominator unverified
|
$277,613,000
7,977,384 shares
|
— | 30 Sep 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$120,064,000
3,450,101 shares
|
— | 30 Sep 2020 |
| Boxer Capital, LLC |
13F
Company
|
—
denominator unverified
|
$115,162,000
3,309,264 shares
|
— | 30 Sep 2020 |
| Cormorant Asset Management, LP |
13F
Company
|
—
denominator unverified
|
$91,878,000
2,640,177 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
118
Shares
57,426,011
Rows available
118
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
90
Q4 2020 holders
118
Holder diff
28
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|